CymaBay Therapeutics, Inc.

CBAYNASDAQHealthcare

$32.48

+$0.01(+0.03%)

Market Cap$3.7B

P/E Ratio—

52W High$32.5

52W Low$7.261

Avg Volume4.2M

Open$32.49

Beta0.32

Employees Ownership Insider Trades

CymaBay Therapeutics, Inc. (CBAY) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CBAY · as of Feb 28, 2024

Latest filing snapshot

101

+41+68.33%vs prior year

CymaBay Therapeutics, Inc. (CBAY) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

101

Change (1Y)

+41

Growth % (1Y)

+68.33%

Revenue / Employee

$307.7K

Net Income / Employee

$-1.04M

Market Cap

$3.7B

CBAY Employee Count

2013 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-02-28	2023-12-31	101	+41	+68.33%
2023-03-23	2022-12-31	60	+1	+1.69%
2022-03-17	2021-12-31	59	+18	+43.90%
2021-03-25	2020-12-31	41	+5	+13.89%
2020-03-16	2019-12-31	36	-7	-16.28%
2019-02-28	2018-12-31	43	+17	+65.38%
2018-03-15	2017-12-31	26	+4	+18.18%
2017-03-23	2016-12-31	22	+1	+4.76%
2016-03-29	2015-12-31	21	+3	+16.67%
2015-03-23	2014-12-31	18	+3	+20.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

MRTX

Mirati Therapeutics, Inc.

Chinook Therapeutics, Inc.

214$2.7B #4

ALPN

Alpine Immune Sciences, Inc.

142$4.5B #5

MORF

Morphic Holding, Inc.

128$2.9B #6

CBAY

CymaBay Therapeutics, Inc.YOU

101$3.7B #7

LBPH

Longboard Pharmaceuticals, Inc.

50$2.3B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CBAY peer comparison

About CBAY employees

CBAY Employees · Headcount

CymaBay Therapeutics, Inc. (CBAY) employee data is sourced from the annual SEC 10-K filing. As of 2023, CymaBay Therapeutics, Inc. had 101 full-time employees globally. Full-time employees only. Global consolidated headcount.

CymaBay Therapeutics, Inc. employs 101 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $307,653, reflecting the company's operational efficiency.

CymaBay Therapeutics, Inc.'s workforce increased by 41 (68.33%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

CymaBay Therapeutics, Inc.'s revenue per employee of $307,653 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CBAY Employees · 5 questions

As of the latest SEC 10-K filing (2023), CymaBay Therapeutics, Inc. had 101 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

CymaBay Therapeutics, Inc. employee counthow many employees does CymaBay Therapeutics, Inc. haveCBAY total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-02-28